Catalyst Pharmaceuticals, INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersCoral Gables, FL
SAM.gov UEIJ1B2ARLKWN53
Catalyst Pharmaceuticals is a biopharmaceutical company that develops and markets approved products for rare and difficult-to-treat conditions, including Lambert-Eaton myasthenic syndrome (LEMS), Duchenne muscular dystrophy (DMD), and epilepsy. The company focuses on recognizing therapeutic potential and moving treatments from research to market, supported by patient advocacy programs and disease education initiatives.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Catalyst Pharmaceuticals, INC | Coral Gables | FL | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.